Introduction

Marie-Paule Kieny, Director of Research, Institut national de la santé et de la recherche médicale (INSERM) and Chair of DNDi Board of Directors

Opening address

Veronika von Messling, Director General, Life Science Division, Federal Ministry of Education and Research, Germany

18:40-19:30

Panel discussion:Meeting the Sustainable Development Goals and Universal Health Coverage with the best science for vulnerable populations

Moderator: Ilona Kickbusch, Chair of the Global Health Centre, Graduate Institute of International and Development Studies, Switzerland

Panelists:

• Jeremy Farrar, Director, Wellcome Trust
• Soumya Swaminathan, Chief Scientist, World Health Organization
• John Amuasi, Executive Director, African Research Network for Neglected Tropical Diseases (ARNTD)

19:30-19:45

Commitment of DNDi’s founding partners

Introduced by Bernard Pécoul, Executive Director, DNDi

Introduction

Bernhards Ogutu, Chief Research Officer, Kenya Medical Research Institute (KEMRI) and DNDi Board Member

Formal address

Veronika von Messling, Director General, Life Science Division, Federal Ministry of Education and Research, Germany

Presentation

Javier Sancho Mas, Coordinator, Chagas Disease Global Coalition

Session 1: Lessons learnt from DNDi’s model within an evolving global R&D landscape

Moderator: Joelle Tanguy, Director External Affairs, DNDi

Speakers:

• Bernard Pécoul, Executive Director, DNDi
• Els Torreele, Executive Director, MSF Access Campaign
• Olivier Brandicourt, Former Chief Executive Officer, Sanofi and Bayer HealthCare AG
• Sherine Helmy, Chief Executive Officer, Pharco Corporation
• Ellen ‘t Hoen, Director, Medicines Law & Policy

Session 2: The three “C”s: Collaboration, Coordination and Cooperation

Moderator: Javid Abdelmoneim, President / Chair of Board of Trustees, Médecins Sans Frontières UK

Speakers:

• Kei Katsuno, Senior Director Investment Strategy & Government Relations, Global Health Innovative Technology Fund (GHIT)
• David Reddy, Chief Executive Officer, Medicines for Malaria Venture
• Luc Kuykens, Senior Vice President, Global Health Programs, Sanofi
• Marco Krieger, Vice President of Production and Innovation in Health, Fundação Oswaldo Cruz (Fiocruz)
• Nathalie Strub-Wourgaft, Director of Neglected Tropical Diseases, DNDi

Remarks

Jane Ruth Aceng, Minister of Health, Ministry of Health, Uganda

Session 3: New Technologies – Hype or hope?

Moderator: Benjamin Perry, Senior Discovery Manager, Open Innovation, DNDi

Speakers:

• Maria Flocco, Vice President, Structure, Biophysics & Fragment-Based Lead Generation, AstraZeneca
• Aled Edwards, Chief Executive Officer, Structural Genomics Consortium
• Sonal Mehta, Chief Executive, India HIV/AIDS Alliance

Session 4: New approaches and ideas to drive public-interest R&D

Moderator: Andrew Jack, Global Education Editor, Financial Times

Speakers:

• Stewart Cole, President, Institut Pasteur, and DNDi Board Member
• James Love, Director, Knowledge Ecology International
• Lenshina Agbor Mpeyako, Researcher, MboaLab/Open Bioeconomy Lab Project
• Graeme Bilbe, R&D Director, DNDi
• Suerie Moon, Co-Director, Global Health Centre, Graduate Institute of International and Development Studies, and Secretary of DNDi Board of Directors

Closing session: Perspectives for the next 15 years

Moderator: Marie-Paule Kieny, Director of Research, Institut national de la santé et de la recherche médicale (INSERM) and Chair of DNDi Board of Directors

Speakers:

• Sylvain Yuma Ramazani, Secretary General, Ministry of Health, Democratic Republic of the Congo
• Marisol Touraine, Former Minister and Chair of the Executive Board of Unitaid, Unitaid
• John Reeder, Director, WHO Special Programme for Research and Training in Tropical Diseases, and Permanent Observer of DNDi Board of Directors
• Noor Hisham Abdullah, Director General of Health, Ministry of Health, Malaysia, and DNDi Board Member